Medical Affairs Platform
Medical grantmaking software for life sciences companies
Bonterra CyberGrants makes it faster and easier for you to process approvals for expanded access, medical education, and research grants programs.
Build customized workflows
Streamline grant review and approvals with automated, tailored workflows and role-based user permissions.
Ensure compliance and reduce risk
Our flexible data enables teams to collect the info they need to make informed, fast grantmaking decisions and ensure robust audit trails for compliance and regulatory teams.
Create a central information hub
Every grant, across every country, feeds into one unified data system — your single source of truth for outcomes, budgets, and milestone updates.
Simplify complex processes
Our team will help you scale back application questions, approval steps, and users involved for peak efficiency.
Bonterra products for life sciences companies
Explore the core Bonterra solutions that power medical grantmaking.
Bonterra CyberGrants created a one-stop location where we can easily view every step of the process and centrally manage all of our data.
Read the case study Solving key medical grantmaking challenges
Our system mitigates common challenges for life sciences companies, making the grant lifecycle efficient and impactful.
Remove obstacles to grant approval
Configure our flexible, rule-based system to streamline the grant approval process and distribute funding without delay.
Eliminate delays and bottlenecks
Work with our team to optimize workflows and implement automations — all while complying with global regulations.
Ensure sufficient data reporting
Understand how your funding made a difference with Bonterra’s Insights dashboards and configurable reports.
FAQs about our medical grantmaking software
No, our medical grantmaking software is not a constituent relationship management (CRM) platform. Rather, our best-in-class grants management solution focuses on streamlining the funding process for life sciences companies.
Resources for leading life sciences companies
Designing modern medical grantmaking
Medical grantmaking is no longer judged by the strength of individual grants. It’s judged by whether those grants collectively change health outcomes across systems. In today’s environment — marked by funding instability, rising accountability standards, and widening inequities — isolated program funding isn’t enough. The real challenge isn’t writing bigger checks or adopting new tools. […]
Choosing the right impact investments
Ready to simplify your grantmaking?